Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing lopinavir (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lopinavir (substance) |
Inferred relationship |
Some |
1 |
Lopinavir + ritonavir 133.3mg/33.3mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lopinavir (substance) |
Inferred relationship |
Some |
|
Lopinavir + ritonavir 80mg/20mg solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lopinavir (substance) |
Inferred relationship |
Some |
|
Lopinavir 133.3 mg and ritonavir 33.3 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lopinavir (substance) |
Inferred relationship |
Some |
|
Product containing lopinavir and ritonavir (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lopinavir (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely lopinavir 80 milligram/1 milliliter and ritonavir 20 milligram/1 milliliter conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lopinavir (substance) |
Inferred relationship |
Some |
|
Lopinavir 200 mg and ritonavir 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lopinavir (substance) |
Inferred relationship |
Some |
|
Lopinavir 100 mg and ritonavir 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lopinavir (substance) |
Inferred relationship |
Some |
|
Product containing lopinavir and ritonavir in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lopinavir (substance) |
Inferred relationship |
Some |
2 |
Product containing lopinavir in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lopinavir (substance) |
Inferred relationship |
Some |
1 |
Lopinavir 133.3 mg and ritonavir 33.3 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lopinavir (substance) |
Inferred relationship |
Some |
1 |
Lopinavir 133.3 mg and ritonavir 33.3 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Lopinavir (substance) |
Inferred relationship |
Some |
1 |
Lopinavir 200 mg and ritonavir 50 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Lopinavir (substance) |
Inferred relationship |
Some |
1 |
Lopinavir 100 mg and ritonavir 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lopinavir (substance) |
Inferred relationship |
Some |
2 |
Lopinavir 100 mg and ritonavir 25 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lopinavir (substance) |
Inferred relationship |
Some |
2 |
Lopinavir 200 mg and ritonavir 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lopinavir (substance) |
Inferred relationship |
Some |
2 |
Lopinavir 200 mg and ritonavir 50 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lopinavir (substance) |
Inferred relationship |
Some |
2 |
Lopinavir 100 mg and ritonavir 25 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Lopinavir (substance) |
Inferred relationship |
Some |
1 |
Lopinavir 200 mg and ritonavir 50 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Lopinavir (substance) |
Inferred relationship |
Some |
1 |
Lopinavir 100 mg and ritonavir 25 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Lopinavir (substance) |
Inferred relationship |
Some |
1 |
Lopinavir 133.3 mg and ritonavir 33.3 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Lopinavir (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely lopinavir 80 milligram/1 milliliter and ritonavir 20 milligram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lopinavir (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely lopinavir 80 milligram/1 milliliter and ritonavir 20 milligram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lopinavir (substance) |
Inferred relationship |
Some |
2 |
Product containing only lopinavir (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lopinavir (substance) |
Inferred relationship |
Some |
1 |
Lopinavir and ritonavir only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lopinavir (substance) |
Inferred relationship |
Some |
2 |
Lopinavir and ritonavir only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lopinavir (substance) |
Inferred relationship |
Some |
2 |
Product containing only lopinavir in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lopinavir (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely lopinavir 40 milligram and ritonavir 10 milligram/1 each conventional release oral pellets in capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Lopinavir (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely lopinavir 40 milligram and ritonavir 10 milligram/1 each conventional release oral pellets in capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Lopinavir (substance) |
Inferred relationship |
Some |
2 |
Lopinavir 133.3 mg and ritonavir 33.3 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lopinavir (substance) |
Inferred relationship |
Some |
2 |
Lopinavir 133.3 mg and ritonavir 33.3 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lopinavir (substance) |
Inferred relationship |
Some |
2 |
Lopinavir 200 mg and ritonavir 50 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lopinavir (substance) |
Inferred relationship |
Some |
2 |
Lopinavir 100 mg and ritonavir 25 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lopinavir (substance) |
Inferred relationship |
Some |
2 |
Lopinavir 40 mg and ritonavir 10 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lopinavir (substance) |
Inferred relationship |
Some |
2 |
Lopinavir 40 mg and ritonavir 10 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lopinavir (substance) |
Inferred relationship |
Some |
2 |